Axa
SWTX

Axa’s SpringWorks Therapeutics SWTX Stock Holding History

Axa’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-107,022
Closed -$2.63M – 1203
2022
Q2 		$2.63M Sell
107,022
-2,079
-2% -$76K 0.01% 726
2022
Q1 		$6.16M Buy
109,101
+1
+0% +$57 0.02% 590
2021
Q4 		$6.76M Buy
109,100
+1,304
+1% +$86.3K 0.02% 588
2021
Q3 		$6.84M Buy
107,796
+3,972
+4% +$306K 0.02% 598
2021
Q2 		$8.56M Sell
103,824
-7,885
-7% -$599K 0.02% 558
2021
Q1 		$8.22M Buy
+111,709
New +$8.75M 0.03% 561

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return